Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
Antisense Oligonucleotides Immobilized on Silicon-Organic Nanoparticles as a Tool for Prolonged Correction of Hypertensive States. / Levina, A. S.; Repkova, M. N.; Klimov, L. O. и др.
в: Bulletin of Experimental Biology and Medicine, Том 167, № 1, 15.05.2019, стр. 116-119.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - Antisense Oligonucleotides Immobilized on Silicon-Organic Nanoparticles as a Tool for Prolonged Correction of Hypertensive States
AU - Levina, A. S.
AU - Repkova, M. N.
AU - Klimov, L. O.
AU - Ryazanova, M. A.
AU - Markel, A. L.
AU - Zarytova, V. F.
PY - 2019/5/15
Y1 - 2019/5/15
N2 - We propose an original method for controlling BP by administration of Si~ODN nanocomposites containing antisense oligonucleotides fixed on silicon-organic nanoparticles. ODN in nanocomposites are targeted to mRNA of the genes encoding angiotensin-converting enzyme (ACE1) and type 1 angiotensin-II receptor (AT1A). The experiments were performed on hypertensive ISIAH rats, a genetic model of hypertension. Single inhalation or intraperitoneal administration of the nanocomposites targeted to ACE1 mRNA or ATA1 mRNA, respectively, led to a pronounced decrease (by ~30 mm Hg) in systolic BP in ISIAH rats over a week. The use of scrambled ODN in the nanocomposites had no effect. A decrease in the expression of ACE1 and AT1A genes under the effect of the corresponding antisense ODN was demonstrated, which attested to directed effect of the test preparations.
AB - We propose an original method for controlling BP by administration of Si~ODN nanocomposites containing antisense oligonucleotides fixed on silicon-organic nanoparticles. ODN in nanocomposites are targeted to mRNA of the genes encoding angiotensin-converting enzyme (ACE1) and type 1 angiotensin-II receptor (AT1A). The experiments were performed on hypertensive ISIAH rats, a genetic model of hypertension. Single inhalation or intraperitoneal administration of the nanocomposites targeted to ACE1 mRNA or ATA1 mRNA, respectively, led to a pronounced decrease (by ~30 mm Hg) in systolic BP in ISIAH rats over a week. The use of scrambled ODN in the nanocomposites had no effect. A decrease in the expression of ACE1 and AT1A genes under the effect of the corresponding antisense ODN was demonstrated, which attested to directed effect of the test preparations.
KW - antisense oligonucleotides
KW - arterial hypertension
KW - nanocomposites
KW - silicon-organic nanoparticles
KW - RNA
UR - http://www.scopus.com/inward/record.url?scp=85067977924&partnerID=8YFLogxK
U2 - 10.1007/s10517-019-04473-5
DO - 10.1007/s10517-019-04473-5
M3 - Article
C2 - 31177453
AN - SCOPUS:85067977924
VL - 167
SP - 116
EP - 119
JO - Bulletin of Experimental Biology and Medicine
JF - Bulletin of Experimental Biology and Medicine
SN - 0007-4888
IS - 1
ER -
ID: 20708577